- Home
- VMD vs MDXG Comparison
VMD vs MDXG Comparison
Compare VMD & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | VMD | MDXG |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 465.4M | 530.2M |
| IPO Year | 2018 | 2007 |
Fundamental Metrics
Financial Performance| Metric | VMD | MDXG |
|---|---|---|
| Price | $12.27 | $4.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 348.1K | ★ 1.2M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.14 | 14.29 |
| EPS | ★ 0.06 | N/A |
| Revenue | $270,280,000.00 | ★ $418,630,000.00 |
| Revenue This Year | $17.88 | N/A |
| Revenue Next Year | $14.98 | $13.02 |
| P/E Ratio | $204.33 | ★ N/A |
| Revenue Growth | ★ 20.52 | 19.99 |
| 52 Week Low | $5.93 | $3.03 |
| 52 Week High | $12.41 | $7.99 |
Technical Indicators
Market Signals| Indicator | VMD | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 78.21 | 63.24 |
| Support Level | $9.26 | $3.50 |
| Resistance Level | N/A | $5.31 |
| Average True Range (ATR) | 0.40 | 0.14 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 93.80 | 72.97 |
Price Performance
Historical ComparisonAbout VMD Viemed Healthcare Inc.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.